Product Information

AUROVELA FE 1-20 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1309 per EA under NDC 65862094088. Its NADAC has been published 373 times since Jul 3, 2019.

FDA first approved this application on Jun 16, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NDC

65862094088

Classification

Generic

Dosage Form

KIT

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207505

FDA Approved

6/16/2017

TE Code

AB

On Market Since

6/16/2017

Price Statistics

The NADAC for AUROVELA FE 1-20 TABLET has been published 373 times since Jul 3, 2019, and over the history we have for it it has declined 57.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1309 per EA
All-time high$0.3795 (Feb 12, 2020)
All-time low$0.1176 (May 22, 2024)
52-week high$0.1517
52-week low$0.1277
Median price$0.1648
Average price$0.2031
Largest weekly change+35.6% (Jun 17, 2020)
Weeks tracked373
Tracking sinceJul 3, 2019

Price History

1W

+0.5%

1M

+0.5%

3M

+0.1%

6M

+2.0%

1Y

-8.7%

3Y

-13.0%

5Y

-53.3%

All

-57.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of AUROVELA FE 1-20 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for AUROVELA FE 1-20 TABLET, manufactured by Aurobindo Pharma Limited, is $0.1309 per EA (NDC 65862094088), effective Aug 19, 2026.

How has the price of AUROVELA FE 1-20 TABLET changed over time?

Over the history we have for it, the NADAC for AUROVELA FE 1-20 TABLET has declined 57.5%. It has been tracked across 373 weekly CMS publications since Jul 3, 2019.

What are the highest and lowest recorded NADAC prices for AUROVELA FE 1-20 TABLET?

Since Jul 3, 2019, the NADAC for AUROVELA FE 1-20 TABLET has ranged from a low of $0.1176 (May 22, 2024) to a high of $0.3795 (Feb 12, 2020), with a median of $0.1648 per EA.

Are there cheaper alternatives to AUROVELA FE 1-20 TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AUROVELA FE 1-20 TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures AUROVELA FE 1-20 TABLET?

AUROVELA FE 1-20 TABLET (NDC 65862094088) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.